A Resolution designating the month of March 2025 as "Endometriosis Awareness Month" in Pennsylvania.
House Resolution 3 designates March 2025 as “Endometriosis Awareness Month” in Pennsylvania. The resolution states that endometriosis is a common but underrecognized condition that can cause severe pelvic pain, infertility, disability, and long delays in diagnosis. It calls attention to the need for greater public and medical awareness, better clinician education, and more research into detection and treatment.
The resolution also goes beyond awareness by urging Congress to support federal research funding for endometriosis, continue that funding annually, and review Medicare and Medicaid billing codes so surgical treatments are reimbursed appropriately. It further encourages creation of a national endometriosis awareness month and asks federal agencies to help educate the public and medical professionals. The measure is a nonbinding resolution, so it does not directly change Pennsylvania statutes or create new state regulatory requirements, but it expresses the House’s policy position and advocacy goals.
The general sentiment reflected in the bill is strongly supportive and sympathetic toward people affected by endometriosis. The findings emphasize the condition’s prevalence, the harm caused by delayed diagnosis, and the underfunding of research, suggesting a public-health and women’s-health framing rather than a partisan one. No committee debate or vote record was provided, so there is no evidence of opposition in the available materials.
The main points of contention implied by the text are not about whether awareness is worthwhile, but about the policy implications of federal funding and reimbursement. The resolution specifically highlights concerns that endometriosis surgery may be under-reimbursed and that research funding is insufficient, which could draw attention from budgetary or health-care payment stakeholders. However, because the measure is only a resolution, any such disputes would likely arise later at the federal level rather than in Pennsylvania law.
HR3 has no direct effect on Pennsylvania statutes, regulations, or appropriations because it is a House resolution rather than a bill creating or amending law. Its practical impact is symbolic and advocacy-oriented: it formally recognizes March 2025 as Endometriosis Awareness Month, encourages education of the public and medical professionals, and transmits the legislature’s support for federal research funding and reimbursement review related to endometriosis treatment. The resolution may help elevate awareness among patients, clinicians, advocacy groups, and federal policymakers, but it does not itself mandate state action or spending.
The available text reflects a clearly favorable and supportive sentiment toward the resolution. The bill’s findings describe endometriosis as common, disabling, underdiagnosed, and underfunded, and the resolution is framed as a call to action to improve awareness, diagnosis, treatment, and research. Because there are no committee transcripts or recorded votes in the provided materials, there is no documented opposition or divided sentiment to report; the measure appears to be presented as a consensus public-health awareness resolution.
No formal contention is documented in the provided committee or voting history, but the resolution itself points to potential policy friction around health-care reimbursement and research funding. The most notable issue is the assertion that excision surgery and other endometriosis-related procedures may not be adequately reimbursed under current Medicare and Medicaid coding, which could concern payers, federal agencies, and budget-focused lawmakers. Another possible point of debate is the call for continued federal funding through Congressionally Directed Medical Research Programs, since that implicates broader appropriations priorities. Still, these are implied policy concerns rather than recorded objections in the available record.